Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Moderna to Present at BMO 2020 Prescriptions for Success Healthcare Conference


Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Stéphane Bancel, Chief Executive Officer, will participate virtually in the BMO 2020 Prescriptions for Success Healthcare Conference on June 23rd at 3:00 p.m. ET.

A live webcast will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for 30 days following the presentation.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and the?Biomedical Advanced Research and Development Authority?(BARDA), a division of the?Office of the Assistant?Secretary for Preparedness and Response (ASPR) within the?U.S. Department of Health and Human Services?(HHS).? Moderna has been named a top biopharmaceutical employer by Science for the past five years. To learn more, visit www.modernatx.com.


These press releases may also interest you

at 18:00
Voxtur Engages ICP Securities Inc. for Automated Market Making Services
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 17:55
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:48
TCTM Filed 2023 Annual Report on Form 20-F
TCTM Kids IT Education Inc. ("TCTM" or the "Company"), a leading provider of IT-focused supplementary STEM education services in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with...

at 17:21
Data Warehouse as a Service Market size to increase by USD 7.91 bilion between 2022 to 2027, Market Segmentation by End-user and Geography, Technavio
The global data warehouse as a service market size is estimated to grow by USD 7915.19 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 21.09% during the forecast period. The Data Warehouse as a Service...

at 17:13
Toronto Stock Exchange, Alithya Group Inc., The View From The C-Suite
Paul Raymond, Alithya Group Inc. ("Alithya"), shares his Company's story in an interview with TMX Group.   The View From The C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX...

at 17:13
Broadridge Schedules Webcast and Conference Call to Review Third Quarter Fiscal Year 2024 Results on May 8, 2024
Broadridge Financial Solutions, Inc.  is scheduled to release its financial results for the third quarter of fiscal year 2024 on Wednesday, May 8, 2024. Broadridge will host a webcast and conference call to discuss those results at 8:30 a.m. ET on...

More news about Science and technology...


News published on and distributed by: